Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus

Internal and Emergency Medicine

Volumn 8, Issue 8, 2013, Pages 705-712

  Vadacca, Marta ^a   Zardi, Enrico M ^a   Margiotta, Domenico ^a   Rigon, Amelia ^a   Cacciapaglia, Fabio ^a   Arcarese, Luisa ^a   Buzzulini, Francesca ^a   Amoroso, Antonio ^b   Afeltra, Antonella ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adipokines; Lupus; Vascular stiffness

Indexed keywords

ADIPONECTIN; LEPTIN;

ADULT; ARTERIAL STIFFNESS; BLOOD; FEMALE; HUMAN; MIDDLE AGED; PATHOPHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADIPONECTIN; ADULT; FEMALE; HUMANS; LEPTIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; VASCULAR STIFFNESS;

EID: 84888288637     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0726-0     Document Type: Article

References (39)

1. Abu-Shakra M, Codish S, Zeller L, Wolak T, Sukenik S (2008) Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience. Isr Med Assoc J 10: 43-44.
2. Cacciapaglia F, Zardi EM, Coppolino G, Buzzulini F, Margiotta D, Arcarese L et al (2009) Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Lupus 18: 249-256.
3. Roman MJ, Shanker BA, Davis A et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Eng J Med 349: 2399-2406.
4. El Magadmi M, Bodill H, Ahmad Y et al (2004) Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 110: 399-404.
5. McMahon M, Grossman J, Skaggs B, Fitzgerald J, Sahakian L, Ragavendra N et al (2009) Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum 30: 2428-2437.
6. Ahmad Y, Shelmerdine J, Bodill H, Lunt M, Pattrick MG, Teh LS et al (2007) Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology (Oxford) 46: 983-988.
7. Doria A, Shoenfeld Y, Wu R (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62: 1071-1077.
8. Pereira RM, de Carvalho JF, Bonfá E (2009) Metabolic syndrome in rheumatological diseases. Autoimmun Rev 8: 415-419.
9. Vadacca M, Margiotta D, Rigon A, Cacciapaglia F, Coppolino G, Amoroso A et al (2009) Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors. J Rheumatol 36: 295-297.
10. Chung CP, Avalos I, Oeser A, Gebretsadik T, Shintani A, Raggi P et al (2007) High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66: 208-214.
11. Ohman MK, Wright AP, Wickenheiser KJ, Luo W, Eitzman DT (2009) Visceral adipose tissue and atherosclerosis. Curr Vasc Pharmacol 7: 169-179.
12. Calabrò P, Golia E, Maddaloni V, Malvezzi M, Casillo B, Marotta C et al (2009) Adipose tissue mediated inflammation: the missing link between obesity and cardiovascular disease? Intern Emerg Med 4: 25-34.
13. Antuna-Puente B, Feve B, Fellahi S, Bastard JP (2008) Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 34: 2-11.
14. Lambert M, O'Loughlin J, Delvin EE, Levy E, Chiolero A, Paradis G (2009) Association between insulin, leptin, adiponectin and blood pressure in youth. J Hypertens 27: 1025-1032.
15. Bo S, Gambino R, Gentile L, Pagano G, Rosato R, Saracco GM et al (2009) High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study. J Hypertens 27: 102-108.
16. Tilg H, Moshen AR (2006) Adipocytochinines: mediators linking adipose tissue, inflammation and immunity. Nature 6: 772-783.
17. Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288: 2031-2041.
18. Lam QL, Lu L (2007) Role of leptin in Immunity. Cellular & Molecular Immunology 4: 1-13.
19. Bełtowski J (2006) Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 24: 789-801.
20. Beltowsku J (2006) Leptin and atherosclerosis. Atherosclerosis 189: 47-60.
21. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N (2001) Plasmaleptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104: 3052-3056.
22. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and metabolic syndrome. J Clin Invest 116: 1784-1792.
23. Han SH (2007) Adiponectin and cardiovascular disease. J Am Coll Cardiol 49: 531-538.
24. Tziomalos K, Tziomalos K, Sivanadarajah N, Mikhailidis DP, Boumpas DT, Seifalian AM (2008) Increased risk of vascular events in systemic lupus erythematosus: is arterial stiffness a predictor of vascular risk? Clin Exp Rheumatol 26: 1134-1145.
25. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA et al (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113: 657-663.
26. Parati G, Bernardi L (2006) How to assess arterial compliance in humans. J Hypertens 24: 1009-1012.
27. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
28. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al (2007) Guidelines for the management of arterial hypertension: the task force for the managementof arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 25: 1105-1187.
29. Griffiths B, Mosca M, Gordon C (2005) Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 19: 685-708.
30. Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupusanticoagulants: an update On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 74: 1185-1190.
31. Von Feldt JM (2008) The cardiovascular threat of lupus. Nat Clin Pract Rheumatol 4: 505.
32. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW et al (2009) Atherosclerosis prevention in pediatric lupus erythematosus investigators. prematureatherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotidintima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosuscohort. Arthritis Rheum 60: 1496-1507.
33. De Leeuw K, Smit AJ, de Groot E, van Roon AM, Kallenberg CG, Bijl M. Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis 2009; 25.
34. Cypiene A, Kovaite M, Venalis A, Dadoniene J, Rugiene R, Petrulioniene Z et al (2009) Arterialwall dysfunction in systemic lupus erythematosus. Lupus 18: 522-529.
35. Shang Q, Tam LS, Li EK, Yip GW, Yu CM (2008) Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. Lupus 17: 1096-1102.
36. Brodszki J, Bengtsson C, Länne T, Nived O, Sturfelt G, Marsál K (2004) Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus. Lupus 13: 917-923.
37. Chow PC, Ho MH, Lee TL, Lau YL, Cheung YF (2007) Relation of arterial stiffness to left ventricular structure and function in adolescents and young adults with pediatric-onset systemic lupus erythematosus. J Rheumatol 6: 1345-1352.
38. McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, et al. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis 2011; June 13.
39. Vadacca M, Margiotta D, Sambataro G, Cacciapaglia F, Rigon A, Buzzulini F, Afeltra A (2010) Leptin levels in patients affected by Sjogren's syndrome and systemic lupus erythematosus. Ann Rheum Dis 69(Suppl3): 573.